Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of [18F]-dopa-PET imaging in assessing movement disorders.

Literature DB >> 15693650

Role of [18F]-dopa-PET imaging in assessing movement disorders.

Abstract

FD-PET has proved to be an extremely useful technique for the noninvasive evaluation of nigrostriatal pathophysiology in patients with PD and other movement disorders. The development of ratio methods for image analysis has greatly reduced the complexity of these PET studies and has facilitated data analysis. With the recent advances in cyclotron targetry and automated synthesis modules FD-PET will soon become an important component of the clinical armamentarium.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2005 PMID： 15693650 DOI： 10.1016/j.rcl.2004.08.002

Source DB: PubMed Journal: Radiol Clin North Am ISSN： 0033-8389 Impact factor: 2.303

Keyword Cloud
Cited

5 in total

1. Brain positron emission tomography with 2-¹⁸F-2-deoxi-D-glucose of patients with dystonia and essential tremor detects differences between these disorders.

Authors: Vadim Belenky; Andrei Stanzhevsky; Olga Klicenko; Alexandr Skoromets
Journal: Neuroradiol J Date: 2017-08-14

Role of [18F]-dopa-PET imaging in assessing movement disorders.

1. Brain positron emission tomography with 2-¹⁸F-2-deoxi-D-glucose of patients with dystonia and essential tremor detects differences between these disorders.

2. Green and efficient synthesis of the radiopharmaceutical [¹⁸F]FDOPA using a microdroplet reactor.

3. The sensitivity and specificity of F-DOPA PET in a movement disorder clinic.

4. Total Radiosynthesis: Thinking outside "the box".

Review 5. Abnormal striatal dopamine transmission in schizophrenia.

Role of [18F]-dopa-PET imaging in assessing movement disorders.

1. Brain positron emission tomography with 2-18F-2-deoxi-D-glucose of patients with dystonia and essential tremor detects differences between these disorders.

2. Green and efficient synthesis of the radiopharmaceutical [18F]FDOPA using a microdroplet reactor.

3. The sensitivity and specificity of F-DOPA PET in a movement disorder clinic.

4. Total Radiosynthesis: Thinking outside "the box".

Review 5. Abnormal striatal dopamine transmission in schizophrenia.

1. Brain positron emission tomography with 2-¹⁸F-2-deoxi-D-glucose of patients with dystonia and essential tremor detects differences between these disorders.

2. Green and efficient synthesis of the radiopharmaceutical [¹⁸F]FDOPA using a microdroplet reactor.